Garetosmab
Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.
Product Specifications
CAS Number
2097125-54-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
TGF-beta/Smad
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP67109_P050 100 µL
GPR21 Antibody - C-terminal region (ARP67109_P050)
Sign In for Pricing
View Details 
MBS2604931-01 48 Well
Canine 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA Kit
Sign In for Pricing
View Details MBS2604931-02 96 Well
Canine 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA Kit
Sign In for Pricing
View Details MBS2604931-03 5x 96 Well
Canine 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA Kit
Sign In for Pricing
View Details MBS2604931-04 10x 96 Well
Canine 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA Kit
Sign In for Pricing
View Details